Spring direct naar de hoofdnavigatie of de inhoud

Life Sciences sector

biotechnology

Home / Sectors / Life Sciences

Life Sciences

Life Sciences

In life sciences, including biotechnology, V.O. represents clients in a broad range of traditional pharmaceutical as well as biological technologies, including immunology, virology, molecular biology, animal and plant genetics, gene therapy, protein chemistry, pharmacology, enzymology, bioinformatics and others. Specific areas of expertise include among others diagnostics, recombinant cytokines, antibody technology, personalized medicine, biomarkers, recombinant antigens and vaccines, and antisense and small RNA technology.

From start-ups to multinationals

Our client base in the life sciences and biotechnology sector ranges from biotech start-ups to multinationals. Working for and with biotech start-ups requires a special approach, as balancing research and commercial development may be complex. The long-term IP strategy, for instance, in which the patent portfolio should be attractive to possible investors and licensees, sometimes seems at odds with the short-term company policy. We know exactly how to provide solutions that are workable and effective.

Renowned experts

Our patent attorneys include renowned experts in biotech and life sciences. Some have worked in the life sciences industry, for instance as researcher. All of them are highly dedicated to their profession, and see it as their mission to help companies to build up a sound and balanced IP portfolio that enables these companies to keep up the good work.

Full-service partner

We provide all IP services: drafting and prosecuting patent applications all over the world. We assist you in defending or attacking patents; in infringement suits and in opposition or invalidity proceedings. Other fields of activity are Freedom To Operate analysis, IP audits and Supplementary Protection Certificates for pharmaceuticals and agrochemicals. Particularly for biotech start-ups we commit ourselves to supporting you throughout the different developmental stages of your company. We help you to integrate IP into your operational management and materialize the knowledge assets of your company.

Contact our experts

Saskia van Doorn

Saskia van Doorn

  • European Patent Attorney
  • Dutch Patent Attorney
  • Senior Associate
More experts

News

Brexit

The impact of Brexit on IP rights

The United Kingdom is expected to leave the European Union on 29 March 2019, with or without a deal. The British Parliament has expressly stated that the existing IP rights that have been established within the EU context will be guaranteed in either case. Below you will find a brief overview of the impact on […]Continue reading

Supplier must warn of potential patent infringement in another country

Imagine that you sell a product that does not fall under the Netherlands’ patent protection to a customer, but your customer then exports the product to Germany where it is protected by a patent. How does this affect your liability?Continue reading

Organ Assist

More organs available thanks to active Organ Assist’s active IP policy

The number of organs transplants in Dutch hospitals is greatly on the rise: with 15% in 2018. This increase is partly the result of the organ perfusion machine developed by Groningen company Organ Assist.Continue reading

Events

Idea, IP & Innovation (3i-) Event

High Tech Campus Eindhoven, High Tech Campus, Eindhoven

On Tuesday 18 April TW.nl organizes the second edition of the 3i-Event. During this inspiring afternoon about Ideas, Intellectual property and Innovation on the Hightech Campus in Eindhoven, R&D professionals, startups and SME entrepreneurs will learn how to set up a successful IP strategy for their companies. More about this event

Knowledge for Growth 2019

Gent ICC, Gent, België

Don’t miss the 2019 edition on 9 May  and capture the attention of 1,200 high-level life sciences actors from about 550 companies & organisations! The cream of the European life sciences community will be attending the 15th edition of flanders.bio’s annual knowledge for growth business conference, attracting decision makers from biotech, pharma and medtech as well as investors, universities, topnotch research institutes, policymakers and competence providers. More about this event